James E Flynn Insider Trading Transactions
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
Latest Insider Trading Transactions of James E Flynn
Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 02 2007 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Sell | S | 7.73 | 31,677 | 244,968 | 413,293 | 445 K to 413.3 K (-7.12 %) |
Feb 01 2007 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 26.90 | 283,185 | 7,618,894 | 2,173,177 | 2.5 M to 2.2 M (-11.53 %) |
Feb 01 2007 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 26.90 | 181,815 | 4,891,605 | 1,395,261 | 1.6 M to 1.4 M (-11.53 %) |
Feb 01 2007 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 26.53 | 25,256 | 669,933 | 2,456,362 | 2.5 M to 2.5 M (-1.02 %) |
Feb 01 2007 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 26.53 | 67,249 | 1,783,827 | 1,577,076 | 1.6 M to 1.6 M (-4.09 %) |
Feb 01 2007 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 27.08 | 14,746 | 399,264 | 0 | 14.7 K to 0 (-100.00 %) |
Feb 01 2007 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 27.08 | 7,933 | 214,795 | 0 | 7.9 K to 0 (-100.00 %) |
Feb 01 2007 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Sell | S | 27.08 | 51,863 | 1,404,248 | 1,644,325 | 1.7 M to 1.6 M (-3.06 %) |
Oct 06 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 4.40 | 376,185 | 1,655,214 | 2,035,137 | 1.7 M to 2 M (+22.68 %) |
Oct 06 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 4.40 | 257,122 | 1,131,337 | 1,516,401 | 1.3 M to 1.5 M (+20.42 %) |
Oct 06 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 4.40 | 105,142 | 462,625 | 433,589 | 328.4 K to 433.6 K (+32.01 %) |
Oct 06 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 4.40 | 211,551 | 930,824 | 866,411 | 654.9 K to 866.4 K (+32.30 %) |
Jul 20 2006 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Buy | P | 13.96 | 196,377 | 2,741,521 | 2,481,618 | 2.3 M to 2.5 M (+8.59 %) |
Jul 20 2006 | PRX | PAR PHARMACEUTICAL ... | Flynn James E | 10% Owner | Buy | P | 13.96 | 134,223 | 1,873,820 | 1,696,188 | 1.6 M to 1.7 M (+8.59 %) |
Jun 05 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 543 | 3,059 | 585,055 | 584.5 K to 585.1 K (+0.09 %) |
Jun 05 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 269 | 1,515 | 290,757 | 290.5 K to 290.8 K (+0.09 %) |
Jun 01 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.77 | 50,804 | 293,144 | 584,512 | 533.7 K to 584.5 K (+9.52 %) |
Jun 01 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.77 | 25,247 | 145,678 | 290,488 | 265.2 K to 290.5 K (+9.52 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.73 | 3,140 | 17,990 | 533,708 | 530.6 K to 533.7 K (+0.59 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.73 | 1,560 | 8,938 | 265,241 | 263.7 K to 265.2 K (+0.59 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.59 | 11,910 | 66,616 | 530,568 | 518.7 K to 530.6 K (+2.30 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.59 | 5,918 | 33,101 | 263,681 | 257.8 K to 263.7 K (+2.30 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.58 | 68,163 | 380,390 | 518,658 | 450.5 K to 518.7 K (+15.13 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.58 | 33,877 | 189,054 | 257,763 | 223.9 K to 257.8 K (+15.13 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 817 | 4,696 | 450,495 | 449.7 K to 450.5 K (+0.18 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 405 | 2,328 | 223,886 | 223.5 K to 223.9 K (+0.18 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.69 | 68,559 | 390,348 | 449,678 | 381.1 K to 449.7 K (+17.99 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.69 | 34,073 | 193,998 | 223,481 | 189.4 K to 223.5 K (+17.99 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 33,581 | 189,860 | 381,119 | 347.5 K to 381.1 K (+9.66 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 16,687 | 94,345 | 189,408 | 172.7 K to 189.4 K (+9.66 %) |
May 18 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.71 | 20,241 | 115,487 | 347,538 | 327.3 K to 347.5 K (+6.18 %) |
May 18 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.71 | 10,059 | 57,393 | 172,721 | 162.7 K to 172.7 K (+6.18 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 6,410 | 36,836 | 327,297 | 320.9 K to 327.3 K (+2.00 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 3,185 | 18,303 | 162,662 | 159.5 K to 162.7 K (+2.00 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.74 | 6,914 | 39,679 | 320,887 | 314 K to 320.9 K (+2.20 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.74 | 3,436 | 19,719 | 159,477 | 156 K to 159.5 K (+2.20 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 37,769 | 217,036 | 313,973 | 276.2 K to 314 K (+13.67 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 18,770 | 107,860 | 156,041 | 137.3 K to 156 K (+13.67 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 25,702 | 144,602 | 276,204 | 250.5 K to 276.2 K (+10.26 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 12,773 | 71,862 | 137,271 | 124.5 K to 137.3 K (+10.26 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.87 | 14,028 | 82,326 | 250,502 | 236.5 K to 250.5 K (+5.93 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.87 | 6,972 | 40,917 | 124,498 | 117.5 K to 124.5 K (+5.93 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 9,286 | 54,787 | 236,474 | 227.2 K to 236.5 K (+4.09 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 4,614 | 27,223 | 117,526 | 112.9 K to 117.5 K (+4.09 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.78 | 5,647 | 32,649 | 227,188 | 221.5 K to 227.2 K (+2.55 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.78 | 2,806 | 16,223 | 112,912 | 110.1 K to 112.9 K (+2.55 %) |
May 11 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.84 | 88,844 | 430,120 | 841,030 | 752.2 K to 841 K (+11.81 %) |
May 11 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.84 | 44,156 | 213,772 | 444,970 | 400.8 K to 445 K (+11.02 %) |
May 11 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.87 | 44,756 | 217,854 | 752,186 | 707.4 K to 752.2 K (+6.33 %) |
May 11 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.87 | 22,244 | 108,275 | 400,814 | 378.6 K to 400.8 K (+5.88 %) |
May 04 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 49,706 | 241,074 | 707,430 | 657.7 K to 707.4 K (+7.56 %) |
May 04 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 24,704 | 119,814 | 378,570 | 353.9 K to 378.6 K (+6.98 %) |
Apr 13 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 6,681 | 32,403 | 657,724 | 651 K to 657.7 K (+1.03 %) |
Apr 13 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 3,319 | 16,097 | 353,866 | 350.5 K to 353.9 K (+0.95 %) |
Apr 13 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 51,661 | 250,556 | 2,484,578 | 2.4 M to 2.5 M (+2.12 %) |
Apr 13 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.85 | 38,339 | 185,944 | 1,888,707 | 1.9 M to 1.9 M (+2.07 %) |
May 15 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.50 | 24,100 | 132,543 | 327,447 | 303.3 K to 327.4 K (+7.94 %) |
May 15 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.50 | 63,565 | 349,588 | 654,860 | 591.3 K to 654.9 K (+10.75 %) |
May 15 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.50 | 10,246 | 56,345 | 591,295 | 581 K to 591.3 K (+1.76 %) |
May 15 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.12 | 3,226 | 16,501 | 581,049 | 577.8 K to 581 K (+0.56 %) |
May 15 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.12 | 1,602 | 8,194 | 304,347 | 302.7 K to 304.3 K (+0.53 %) |
May 02 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.71 | 11,200 | 63,945 | 577,823 | 566.6 K to 577.8 K (+1.98 %) |
May 02 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.71 | 200 | 1,142 | 302,745 | 302.5 K to 302.7 K (+0.07 %) |
May 02 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.72 | 5,211 | 29,785 | 566,623 | 561.4 K to 566.6 K (+0.93 %) |
May 02 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.72 | 2,589 | 14,798 | 302,545 | 300 K to 302.5 K (+0.86 %) |
May 02 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.50 | 28,701 | 157,856 | 1,658,952 | 1.6 M to 1.7 M (+1.76 %) |
May 02 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.50 | 21,299 | 117,145 | 1,259,279 | 1.2 M to 1.3 M (+1.72 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.55 | 12,065 | 66,964 | 561,412 | 549.3 K to 561.4 K (+2.20 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.55 | 5,996 | 33,280 | 299,956 | 294 K to 300 K (+2.04 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.55 | 31,102 | 172,625 | 1,630,251 | 1.6 M to 1.6 M (+1.94 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.55 | 23,082 | 128,112 | 1,237,980 | 1.2 M to 1.2 M (+1.90 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.43 | 6,680 | 36,297 | 549,347 | 542.7 K to 549.3 K (+1.23 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.43 | 3,320 | 18,040 | 293,960 | 290.6 K to 294 K (+1.14 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.43 | 17,220 | 93,568 | 1,599,149 | 1.6 M to 1.6 M (+1.09 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.43 | 12,780 | 69,443 | 1,214,898 | 1.2 M to 1.2 M (+1.06 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.48 | 1,994 | 10,923 | 542,667 | 540.7 K to 542.7 K (+0.37 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.48 | 990 | 5,423 | 290,640 | 289.7 K to 290.6 K (+0.34 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.48 | 15,416 | 84,450 | 1,581,929 | 1.6 M to 1.6 M (+0.98 %) |
Apr 24 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.48 | 11,440 | 62,669 | 1,202,118 | 1.2 M to 1.2 M (+0.96 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.02 | 13,180 | 79,295 | 552,304 | 539.1 K to 552.3 K (+2.44 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.02 | 9,779 | 58,833 | 298,661 | 288.9 K to 298.7 K (+3.39 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.02 | 1,549 | 9,319 | 1,554,882 | 1.6 M to 1.6 M (+0.10 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.02 | 768 | 4,621 | 1,181,667 | 1.2 M to 1.2 M (+0.07 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 1,761 | 10,626 | 539,124 | 537.4 K to 539.1 K (+0.33 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 874 | 5,274 | 288,882 | 288 K to 288.9 K (+0.30 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 26,678 | 160,980 | 1,553,333 | 1.5 M to 1.6 M (+1.75 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 19,796 | 119,453 | 1,180,899 | 1.2 M to 1.2 M (+1.70 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 32,132 | 193,804 | 537,363 | 505.2 K to 537.4 K (+6.36 %) |
Apr 05 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 15,968 | 96,311 | 288,008 | 272 K to 288 K (+5.87 %) |
Mar 09 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.95 | 53,430 | 264,238 | 651,043 | 597.6 K to 651 K (+8.94 %) |
Mar 09 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.95 | 28,770 | 142,282 | 350,547 | 321.8 K to 350.5 K (+8.94 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.74 | 1,024 | 4,854 | 597,613 | 596.6 K to 597.6 K (+0.17 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.75 | 23,267 | 110,525 | 596,589 | 573.3 K to 596.6 K (+4.06 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.55 | 33,032 | 150,296 | 573,322 | 540.3 K to 573.3 K (+6.11 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.74 | 551 | 2,612 | 321,777 | 321.2 K to 321.8 K (+0.17 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.75 | 12,527 | 59,507 | 321,226 | 308.7 K to 321.2 K (+4.06 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.55 | 17,785 | 80,922 | 308,699 | 290.9 K to 308.7 K (+6.11 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.74 | 4,388 | 20,799 | 2,431,397 | 2.4 M to 2.4 M (+0.18 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.72 | 85,200 | 402,144 | 2,427,009 | 2.3 M to 2.4 M (+3.64 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.75 | 99,694 | 473,576 | 2,341,809 | 2.2 M to 2.3 M (+4.45 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.55 | 141,536 | 643,989 | 2,242,115 | 2.1 M to 2.2 M (+6.74 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.74 | 3,337 | 15,817 | 1,849,213 | 1.8 M to 1.8 M (+0.18 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.72 | 64,800 | 305,856 | 1,845,876 | 1.8 M to 1.8 M (+3.64 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.75 | 75,822 | 360,177 | 1,781,076 | 1.7 M to 1.8 M (+4.45 %) |
Feb 24 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.55 | 107,647 | 489,794 | 1,705,254 | 1.6 M to 1.7 M (+6.74 %) |
Mar 30 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.78 | 1,520 | 7,266 | 2,432,917 | 2.4 M to 2.4 M (+0.06 %) |
Mar 30 2006 | ISPH | INSPIRE PHARMACEUT ... | Flynn James E | 10% Owner | Buy | P | 4.78 | 1,155 | 5,521 | 1,850,368 | 1.8 M to 1.9 M (+0.06 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.91 | 1,122 | 6,630 | 505,231 | 504.1 K to 505.2 K (+0.22 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.91 | 603 | 3,563 | 272,040 | 271.4 K to 272 K (+0.22 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.91 | 7,248 | 42,832 | 1,526,655 | 1.5 M to 1.5 M (+0.48 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.91 | 5,511 | 32,567 | 1,161,103 | 1.2 M to 1.2 M (+0.48 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.02 | 2,938 | 17,694 | 504,109 | 501.2 K to 504.1 K (+0.59 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.02 | 1,581 | 9,521 | 271,437 | 269.9 K to 271.4 K (+0.59 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.02 | 18,981 | 114,311 | 1,519,407 | 1.5 M to 1.5 M (+1.27 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.02 | 14,434 | 86,927 | 1,155,592 | 1.1 M to 1.2 M (+1.26 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.95 | 5,281 | 31,439 | 501,171 | 495.9 K to 501.2 K (+1.06 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.95 | 2,843 | 16,925 | 269,856 | 267 K to 269.9 K (+1.06 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.95 | 34,119 | 203,121 | 1,500,426 | 1.5 M to 1.5 M (+2.33 %) |
Mar 17 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.95 | 25,948 | 154,476 | 1,141,158 | 1.1 M to 1.1 M (+2.33 %) |
Mar 09 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 1,185 | 7,144 | 495,890 | 494.7 K to 495.9 K (+0.24 %) |
Mar 09 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 638 | 3,846 | 267,013 | 266.4 K to 267 K (+0.24 %) |
Mar 09 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 7,655 | 46,147 | 1,466,307 | 1.5 M to 1.5 M (+0.52 %) |
Mar 09 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.03 | 5,822 | 35,097 | 1,115,210 | 1.1 M to 1.1 M (+0.52 %) |
Mar 09 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.00 | 11,375 | 68,250 | 494,705 | 483.3 K to 494.7 K (+2.35 %) |
Mar 09 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 6.00 | 6,125 | 36,750 | 266,375 | 260.3 K to 266.4 K (+2.35 %) |
Mar 07 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 9,840 | 58,068 | 483,330 | 473.5 K to 483.3 K (+2.08 %) |
Mar 07 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 5,295 | 31,247 | 260,250 | 255 K to 260.3 K (+2.08 %) |
Mar 07 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 59,128 | 348,926 | 1,458,652 | 1.4 M to 1.5 M (+4.22 %) |
Mar 07 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 44,967 | 265,359 | 1,109,388 | 1.1 M to 1.1 M (+4.22 %) |
Feb 10 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.68 | 24,624 | 139,822 | 1,399,524 | 1.4 M to 1.4 M (+1.79 %) |
Feb 10 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.68 | 18,726 | 106,332 | 1,064,421 | 1 M to 1.1 M (+1.79 %) |
Feb 08 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 11,232 | 63,460 | 466,232 | 455 K to 466.2 K (+2.47 %) |
Feb 08 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 21,993 | 124,258 | 1,328,394 | 1.3 M to 1.3 M (+1.68 %) |
Feb 08 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 6,048 | 34,171 | 251,048 | 245 K to 251 K (+2.47 %) |
Feb 08 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 16,727 | 94,506 | 1,010,326 | 993.6 K to 1 M (+1.68 %) |
Feb 08 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.68 | 7,258 | 41,213 | 473,490 | 466.2 K to 473.5 K (+1.56 %) |
Feb 08 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.68 | 46,506 | 264,075 | 1,374,900 | 1.3 M to 1.4 M (+3.50 %) |
Feb 08 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.68 | 3,907 | 22,185 | 254,955 | 251 K to 255 K (+1.56 %) |
Feb 08 2006 | DVAX | DYNAVAX TECHNOLOGI ... | Flynn James E | 10% Owner | Buy | P | 5.68 | 35,369 | 200,836 | 1,045,695 | 1 M to 1 M (+3.50 %) |